Chris Lawer
I lead Strategyn UK and work with global companies to help them become successful customer-centred innovators. My team has identified numerous high-value, pre-concept market opportunities and created growth plans that work. Find us at http://www.strategyn.co.uk I also lead ZinC - a healthcare technology opportunity, innovation and growth strategy consultancy. We have tailored customer-centered innovation theory, methods and processes for healthcare markets. Find us at Http://www.zinc-healthcare.com
I thought I would share a typology of common issues that I think plague the "opportunity discovery, selection and targeting" first phase of innovation,...
Based on an extensive analysis of the academic co-creation literature and my previous work into market-learning capabilities, in this paper i provide a conceptual...
According to the International Diabetes Federation, there are more than 240 million people worldwide with diabetes, a number expected to grow to close to...
I try and shape my thinking and therefore I guess, my definition of co-creation in terms of how the concept can help firms achieve their growth goals through innovating...
(with Tony Ulwick, Strategyn CEO) When managed correctly, open, customer-driven innovating firms enjoy competitive advantage arising from a number of sources. These include; better “unlearning”...
My perspective of co-creation is rooted in the knowledge-based view of the firm. Firms exist because they can integrate and coordinate specialized knowledge held by...
A perspective of the firm as an autonomous knowledge creator that learns about customers and creates value for them is increasingly redundant. Now, firms...
This paper by Tony Ulwick, Strategyn provides a summary of the Strategyn Outcome-Driven Innovation method, describing 8 key discoveries that define the approach. These...